Piedmont Investment Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Piedmont Investment Advisors's DGX Position: Q2 2020 in Review
Piedmont Investment Advisors sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 2,582 shares — an estimated $207K sold.
Piedmont Investment Advisors first reported a position in DGX in Q2 2014 and held it in 22 quarters. The position peaked at $6.67M in Q1 2017. 749 funds tracked by Wall St. Rank hold DGX as of Q2 2020.
- Piedmont Investment Advisors reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
- Piedmont Investment Advisors sold 2,582 Quest Diagnostics shares in Q2 2020, an estimated $207K.
- Piedmont Investment Advisors first reported a position in Quest Diagnostics in Q2 2014 and held it in 22 quarters.
- Piedmont Investment Advisors's Quest Diagnostics position peaked at $6.67M in Q1 2017.
- 749 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.
Based on Piedmont Investment Advisors's 13F filing for Q2 2020.